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Abstract
Purpose Excessive movements during walking have been
observed by gait analysis in children with arthrogryposis
(AMC) using orthoses compared to children using only
shoes. The aim of this study was to evaluate energy
expenditure and functional exercise capacity in children
with AMC.
Methods Twenty-four children with AMC and 25 typi-
cally developing (TD) children underwent oxygen mea-
surement and the 6-minute walk test (6MWT). Children
were divided into AMC1 using knee–ankle–foot orthoses
with locked knee joints (KAFO-LK); AMC2 KAFOs with
open knee joints (KAFO-O) or ankle–foot orthoses (AFO);
and AMC3 using shoes.
Results The net non-dimensional oxygen cost (NNcost)
was lower in TD (0.308) than in AMC2 (0.455, n = 10)
(p = 0.002). There were no differences in the net non-
dimensional consumption (NNconsumption) or normalised
walking velocity. The lowest NNconsumption (0.082),
NNcost (0.385) and normalised walking velocity (0.214)
were found in AMC1 (n = 3), but no statistical calculation
was performed. In the 6MWT, both AMC2 (402.7, n = 11)
and AMC3 (476.8, n = 10) walked shorter distances
(m) than TD (565.1) (p \ 0.001 and p = 0.043, respec-
tively). AMC2 (0.435) had lower normalised walking
velocity than TD (0.564) (p \ 0.001).
Conclusions Children with AMC using open KAFOs or
AFOs (AMC2) had higher energy effort represented by
significantly higher NNcost than TD, whereas AMC children
requiring only shoes (AMC3) did not differ significantly
from TD. To maintain the NNconsumption at an acceptable
level, children using locked KAFOs (AMC1) slowed down
their walking velocity. Compared to TD, the exercise
capacity was lower in children with AMC using open KA-
FOs or AFOs and shoes, represented by lower walking
velocity and shorter distance walked during the 6MWT.
Keywords Ambulation  Amyoplasia  Oxygen
consumption  Oxygen cost  Physical capacity
Introduction
Arthrogryposis (AMC) is characterised by the presence of
multiple joint contractures in multiple body areas that are
present at birth [1], with a reported incidence from 1 per
3,000 to 1 per 5,100 live births [1, 2]. It has been defined as
a rare but heterogeneous disorder [3] with different sub-
types, of which amyoplasia is the most common [1]. The
ability of functional ambulation depends on factors such as
the severity of lower limb deformities and muscle weak-
ness in the lower limbs, primarily in the hip and knee
extensor muscles [4, 5]. Independent walking before the
age of 2.5 years has been reported [5], and 85 % of chil-
dren with amyoplasia were found to be ambulators by the
age of 5 years [6]. The presence of muscle weakness in the
lower extremities was assumed to have more influence on
walking ability than the severity of contractures [7]. For
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efficient mobility, the use of a wheelchair may be required
[3, 6, 8].
Orthopaedic surgery with multiple procedures is often
necessary to achieve functional ambulation [3]. Orthoses are
also often used to enhance or facilitate walking and to
compensate for muscle weakness and lower extremity
deformities, as well as to maintain the lower extremities in an
aligned position [4, 9]. The most commonly used orthoses
types in children with AMC are ankle–foot orthoses (AFOs)
or knee–ankle–foot orthoses (KAFOs) with a knee locking
mechanism [4, 9]. In children with plantarflexor weakness,
orthoses with a carbon fibre spring ankle joint were consid-
ered to improve gait, as measured by 3-D gait analysis [10].
Variations in gait pattern with respect to orthosis use have
been observed; in children using KAFOs with locked knee
joints, more extensive trunk and pelvic movements were
observed compared to children using AFOs and shoes [11]. It
may, thus, be assumed that physical effort during walking is
high in children with AMC.
Various methods have been proposed to assess physical
effort during walking. A functional exercise capacity test has
been developed for use during a 6-min walking period that
reflects the functional level for daily physical activities [12].
The physiological cost index (PCI) offers a value of the heart
rate per metre walked [13]. Although assuming a linear
relation between heart rate and oxygen consumption [14], the
PCI method has been criticised for use in children with dis-
abilities, due to the children’s difficulties in achieving a state
of steady heart rate during walking [15, 16]. Instead, the
measurement of oxygen uptake has been recommended,
allowing calculation of the oxygen consumption and cost,
referred to as physical effort and indicator of the efficiency of
walking, respectively [17]. To reduce the variability between
participants of different ages, a non-dimensional normalisa-
tion scheme for oxygen data has been proposed [18]. The
scheme uses the net oxygen utilisation instead of gross oxy-
gen utilisation, the former evaluating solely the amount of
energy used to ambulate except resting time [18].
In youths with AMC, the ambulatory and physical
activity has been studied using a step activity monitor and
was found to be lower compared to that of typically
developing (TD) youths [19]. To our knowledge, there is
no report on energy effort; thus, the aim of this study was
to evaluate energy expenditure and exercise capacity dur-
ing walking in children with AMC.
Methods
Participants
Children with AMC born between the years 1993 and
2007, who were treated at the children’s orthopaedic
department of Karolinska University Hospital, Stockholm
and at the Uppsala University Children’s Hospital, were
invited to participate in the study. Thirty-one children
fulfilled the inclusion criteria of lower limb deformities or
contractures, independent ambulation with or without
orthoses, and age between 5 and 18 years. None of the
children had undergone orthopaedic surgery in the past
12 months. Of the 31 children eligible for inclusion, seven
families declined participation, thus, 24 children with a
mean age of 11.1 (4.3) years took part in the study between
April 2011 and March 2012. Twenty-five TD children with
a mean age of 11.4 (4.1) years constituted the control
group. The study was approved by the Regional Ethical
Review Board in Stockholm, Sweden. Written informed
consent was obtained from the participants and their
parents.
The children were divided into three groups based on
orthosis use, as has been described in a previous study [11]:
AMC1 (n = 3) wore KAFOs with locked knee joints
(KAFO-LK); in AMC2 (n = 11), 3/11 children wore
KAFOs with open knee joints (with an extension stop)
(KAFO-O), 7/11 wore AFOs of different types and 1/11
wore KAFO-LK with compensation for limb length dis-
crepancy and a foot orthosis (FO); and AMC3 (n = 10)
used shoes. The distributions of gender, age, height and
weight are shown in Table 1. Prescriptions of orthoses
were based on the presence of muscle weakness, joint
contractures and deformities according to the orthotic
programme of Karolinska University Hospital. In AMC1,
the locked knee joints were prescribed due to knee extensor
weakness. In this group, two children used carbon fibre
springs (Fig. 1). In AMC2, KAFO-Os with free flexion
were prescribed in one child with hyperextension and in
two children to control foot and thigh alignment, all of
them with carbon fibre springs (Fig. 2). AFOs with carbon
fibre springs (Fig. 3) were prescribed in two children with
plantarflexor weakness. Five children had various AFO
types (two solid, two hinged and one flexible carbon fibre)
Table 1 Distributions of gender, age, height and weight mean (SD)
in the groups
AMC1 AMC2 AMC3 TD
Gender
Male 3 9 4 17
Female – 2 6 8
Age (years) 16.8 (0.2) 10.0 (4.1) 10.7 (4.1) 11.4 (4.1)
Height (cm) 169.0 (3.5) 132.6 (22.8) 135.8 (25.2) 148.8 (24.1)
Weight (kg) 70.7 (27.0) 29.9 (12.0) 35.3 (14.9) 43.6 (18.0)
AMC arthrogryposis multiplex congenita, AMC1 used knee–ankle–
foot orthoses with locked knee joints, AMC2 used knee–ankle–foot
orthoses with open knee joints or ankle–foot orthoses, AMC3 used
shoes, TD typically developing children
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to stabilise the foot and ankle joint based on material cri-
teria due to weight and acceptance of orthoses (Table 2).
All children used their orthoses for 8 h or more daily.
Nineteen children were community ambulators, 11 with
no need for a wheelchair and eight with the need for a
wheelchair for longer distances outdoors, and five children
were household ambulators (Table 2) [20].
The strength of the lower limb muscles was tested
manually according to a 0–5 graded scale [21], with 5
indicating normal strength to grade 0 indicating the
absence of muscle strength. Hip extension and hip abduc-
tion ranged between grades 4 and 5, knee extension
between grades 0 and 5, and ankle dorsiflexion and plan-
tarflexion between grades 0 and 5 (Table 2).
Hip and knee flexion contractures were defined as C108
from a neutral joint position, and plantarflexion contrac-
tures as less than a neutral position. Knee hyperextension
was defined as [108 from a neutral position. Flexion
contractures uni- or bilaterally were seen in the ankle in 12
children, in the knee in nine and in the hip in six children.
Knee hyperextension uni- or bilaterally was seen in six
children (Table 2). Assessment of muscle strength and
joint range of motion were performed by the same phys-
iotherapist (LV).
Twenty-two participants had undergone orthopaedic
surgery, of which 19 had bony surgery and three soft tissue
surgery (Table 2).
O2-walking test and 6-minute walk test (6MWT)
Energy expenditure was measured as the rate of oxygen
uptake during walking at a self-selected speed using the
portable telemetric system Cosmed K4b2 (Cosmed Srl,
Rome, Italy), which is a valid and reliable method to
measure energy during walking in children with disabilities
[15].
Functional exercise capacity was measured with the
6MWT, which is a valid and reliable method for assessing
endurance and exercise tolerance in healthy children [22]
and in children with disabilities [23]. The heart rate was
measured with a polar heart rate monitor (Polar Electro Oy,
Kempele, Finland).
Fig. 1 Knee–ankle–foot
orthosis with locked knee joint
and carbon fibre spring ankle
joint (KAFO-LK-C)
Fig. 2 Knee–ankle–foot
orthosis with open knee joint
and extension stop, and carbon
fibre spring ankle joint (KAFO-
O-C)
Fig. 3 Ankle–foot orthosis with carbon fibre spring ankle joint
(AFO-C)
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Both the O2-walking test and the 6MWT were per-
formed on the same 21-m oval walking track in the gait
laboratory. The 6MWT was performed after completion of
the O2 measurement.
Prior to the O2-walking test, the child was given
verbal instructions and the opportunity to become
familiar with the equipment. The test was standardised to
5 min rest, followed by 5 min walking at a self-selected
speed and completed by 5 min rest after the test. During
the two resting periods, the child was asked to sit quietly
in a comfortable chair in order to achieve a stable heart
rate.
Prior to the 6MWT, it was assured that the heart rate
was at a stable resting steady-state level. Each child was
instructed to cover as long a distance as possible in
6 min, without running. Encouragement such as ‘‘keep
going’’ and ‘‘you are doing well’’, as well as announce-
ment of the time remaining, was given to the child with
respect to the guidelines of the American Thoracic
Society (ATS) [24].
Data analysis
Oxygen consumption was measured in terms of the rate of
oxygen consumed while walking, both as normalised by
body weight per unit time (ml/kg/min) and as oxygen cost
per metre walked during the test (ml/kg/m) [17]. Gross
oxygen consumption and gross oxygen cost, including
both resting and walking oxygen utilisation, were calcu-
lated from the last 2 min of the walking period and were
normalised by body weight and the weight of orthoses
and shoes. To calculate the net oxygen consumption, the
oxygen consumption at rest was subtracted from the
oxygen consumption during walking. The last 2 min of
the first resting period and the last 2 min of the walking
period were used to calculate the net non-dimensional
consumption (NNconsumption) and cost (NNcost). The
net non-dimensional values were calculated including
parameters of body weight, leg length and the accelera-
tion due to gravity [18]. The weight of orthoses and shoes
were included in the equation. The 6MWT was analysed
based on the distance walked and the mean walking
velocity during the complete test. For both tests, the
walking velocity was normalised to leg length and is
presented as the normalised walking velocity (N walking
velocity) [25].
Statistical analysis
AMC1 was excluded from the statistical comparison with
the other groups because of the low participant number,
with only descriptive statistics reported as mean (SD). A
one-way analysis of variance (ANOVA) was used to
compare values between AMC2, AMC3 and TD children.
To identify significant differences among means between
groups, a post hoc analysis was performed using Fisher’s
least significant difference (LSD) test. All statistical anal-
yses were carried out using commercially available soft-
ware (SPSS version 19.0). A p-value of B0.05 was
considered to be statistically significant.
Results
O2-walking test
One child in AMC2 and one in AMC3 did not complete the
test.
The gross oxygen consumption (ml/kg/min) ranged in
AMC1 between 10.15 and 14.56, in AMC2 between
16.38 and 29.20, in AMC3 between 12.92 and 25.69,
and in TD children between 11.51 and 24.94. The gross
oxygen cost (ml/kg/m) ranged in AMC1 between 0.28
and 0.40, in AMC2 between 0.21 and 0.71, in AMC3
between 0.19 and 0.41, and in TD children between 0.16
and 0.43. The walking velocity (m/s) was in AMC1 0.61,
ranged in AMC2 between 0.60 and 1.31, in AMC3
between 0.55 and 1.29, and in TD children between 0.75
and 1.45.
NNconsumption was higher in AMC2 and AMC3 than
in the TD children, but not significantly. NNcost was
higher in AMC2 and AMC3 than in the TD children. As
analysed with Fisher’s LSD post hoc test, AMC2 had
significantly higher NNcost than TD children. N walking
velocity was lower in AMC2 than in AMC3 and the TD
children, but not significantly (Table 3).
In AMC1, the NNconsumption mean (SD) was 0.082
(0.008), the NNcost mean (SD) was 0.385 (0.031) and the
N walking velocity mean (SD) was 0.214 (0.005).
6MWT
The walking velocity (m/s) ranged in AMC1 between 0.82
and 0.93, in AMC2 between 0.66 and 1.53, in AMC3
between 0.81 and 1.88, and in TD children between 0.96
and 1.98.
The walked distance differed significantly between
AMC2, AMC3 and the TD children. As analysed with
Fisher’s LSD post hoc test, TD children walked a signifi-
cantly longer distance than AMC2 and AMC3. N walking
velocity differed significantly between AMC2, AMC3 and
the TD children. As analysed with Fisher’s LSD post hoc
test, AMC2 had significantly lower N walking velocity
than TD children (Table 4).
AMC1 walked a mean (SD) distance of 312.0 (19.7) m
and had a N walking velocity mean (SD) of 0.304 (0.015).
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Discussion
The results in this study confirm that the energy effort
during walking at a self-selected speed is increased in
children with AMC. This was seen as higher NNcon-
sumption in AMC2 and AMC3 than in the TD children, as
well as a higher NNcost in AMC2 and AMC3 compared to
TD children, which indicates a less efficient gait in children
with AMC. Higher N walking velocity was found in all
groups during the 6MWT compared to the O2-walking test,
which was expected, as the instructions on walking speed
differed between the two tests. Another explanation is that
wearing the mask during the O2-walking test may have
reduced the visual field, possibly influencing walking
velocity. In this study, we included children aged
5–17 years, and, therefore, we chose to normalise the data
with the net non-dimensional scheme, which has been
recommended when including children of different ages
[18].
Since orthoses aim to stabilise joints, they influence both
gait pattern and walking function. We, therefore, divided
the participants into groups according to their orthoses, as
has been described in a previous study [11]. Among the
AMC groups, the lowest NNcost was found in AMC1. We
could not, however, confirm this observation statistically
due to the low participant number. Children in AMC1
required above-knee orthotic solutions with locked knee
joints and were totally dependent on orthoses to achieve
walking ability. This group had the lowest NNconsumption
of all groups, including TD children, which is probably
related to their low walking velocity to decrease physical
exertion. In normal gait, the knee flexes during the swing
phase [26], which is not possible in a locked KAFO.
Compensatory movements such as pelvic hiking or
circumduction of the leg [26] are, therefore, necessary. In
persons with knees immobilised with a cast, reduced
walking speed and increased oxygen cost have been
reported [27]. In AMC1, it was possible to maintain the
oxygen consumption at an acceptable level by reducing
walking velocity, which contributes to an increase in
oxygen cost. The highest NNcost was found in AMC2, of
whom all needed orthoses and all except two children were
community ambulators.
Joint contractures, which are the main characteristics in
AMC, were frequently found in the ankle joint in AMC1
and in AMC2, but only in two children in AMC3. The
children in AMC3, who use only shoes, reached walking
speeds most similar to the TD children during the O2-
walking test. This may be due to not only fewer joint
contractures than the other AMC groups, but also to the
good plantarflexor strength in all children in AMC3. All
participants had good muscle strength in hip extensors and
hip abductors, and only one child had a hip flexion con-
tracture of 20. The presence of hip flexion contracture
\20 and active hip motion were reported to be important
factors to maintain community or independent walking [5].
Walking distance is the main outcome measure in the
6MWT [24]. The children with AMC walked shorter dis-
tances than the TD children, wherein children in AMC1
walked the shortest distance, which reflects the difficulties
in keeping up with peers and, therefore, making wheelchair
use necessary and useful. The large variety in walked
distance within the AMC2, AMC3 and TD groups, how-
ever, may partly be explained by age variations, as this
parameter was not normalised. The adolescents in AMC1
ambulated indoors using orthoses with locked knee joints
and used powered wheelchairs for transportation. This is in
accordance with Murray and Fixsen [28], who reported that
Table 3 Normalised oxygen consumption (NNconsumption), normalised oxygen cost (NNcost) and normalised walking velocity in AMC2,
AMC3 and TD children during the O2-walking test
AMC2 (n = 10)
(mean, SD)
AMC3 (n = 9)
(mean, SD)








NNconsumption 0.156 (0.053) 0.159 (0.070) 0.123 (0.028) 0.055 – – –
NNcost 0.455 (0.193) 0.398 (0.146) 0.308 (0.069) 0.007 0.319 0.002 0.067
N walking velocity 0.361 (0.072) 0.401 (0.093) 0.403 (0.050) 0.223 – – –
N normalised, AMC arthrogryposis multiplex congenita, TD typically developing children
Table 4 Walked distance and normalised walking velocity in AMC2, AMC3 and TD children during the 6-minute walk test (6MWT)
AMC2 (n = 11)
(mean, SD)
AMC3 (n = 10)
(mean, SD)








Distance (m) 402.7 (108.0) 476.8 (126.1) 565.1 (110.0) 0.001 0.141 \0.001 0.043
N walking velocity 0.435 (0.030) 0.501 (0.100) 0.564 (0.073) 0.001 0.088 <0.001 0.055
m metres, N normalised, AMC arthrogryposis multiplex congenita, TD typically developing children
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adolescents felt more integrated into the community in a
wheelchair than walking with crutches and orthoses. To
meet each individual’s requirements, we recommend a
combination of wheelchair and orthoses use for children
who use orthoses for walking function. The requirement of
walkers has been described in children walking with KA-
FOs, and often with forearm support instead of standard
walker grips [9]. Furthermore, limited ambulation due to
poor protective responses of the upper extremity has been
reported [9]. Fifteen of 24 children in our study had upper
limb involvement, of which two had locked KAFOs
bilaterally, though none used a walking aid. This is
believed to be due to the stable orthosis construction
offering the children sufficient stability to walk without an
external walking aid. Another important treatment goal is
to improve biomechanical alignment with adequate ortho-
ses and footwear combinations [29]. In our participants,
heel height was adjusted in the orthoses and/or the shoes,
when required, for each child’s contracture.
While lower ambulatory and physical activity has been
reported in youths with AMC compared to TD youths [19],
this is, to our knowledge, the first study on physical effort
in children with AMC. The small number of participants
and the heterogeneity in this study are limitations. Simul-
taneously, they reflect the rarity and complexity of this
condition. A walking test of longer duration or walking at
higher or fixed speeds may have discriminated even more
between the groups. This, however, may have further
reduced the study population due to limited endurance,
which has been reported in youths with AMC [19]. Nev-
ertheless, the self-selected speed which was chosen in this
study has been suggested to be the best simulation of how
children with disabilities function in the community [15].
Conclusion
Energy expenditure and functional exercise capacity were
evaluated in children with AMC during walking in their
habitual orthoses, ranging from KAFO with locked knee
joints, to AFO, to shoes only. The energy effort during
walking at a self-selected speed was higher in children with
AMC than in TD children The children walking with open
KAFOs or AFOs, most of whom were community ambu-
lators, walked with almost the same N walking velocity as
AMC children not using orthoses and TD children. Their
NNcost, however, was higher, which indicates a less effi-
cient gait in this group. The children walking with KAFO
with locked knee joints were totally dependent on orthoses
to achieve walking ability. They had the lowest N walking
velocity of all groups, and reducing walking velocity is
interpreted as a strategy to minimise exertion. During the
exercise capacity test in the 6MWT, the children with
AMC walked a shorter distance than the TD children,
which reflects their difficulties in keeping up with peers.
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